Cereplast, Inc. (CERP.OB) to Transform Algae into Bioplastics with Breakthrough Technology

QualityStocks — Wed, 21 Oct 2009 14:14:28 +0000

In 1996, Frederic Scheer had a vision when he began to market the concept of compostable plastics. This vision led Cereplast from a pioneer to a leader in the bioplastics industry. Yesterday, the vision of Mr. Scheer and the team at Cereplast provided a breakthrough announcement that will change the face of their [...]

MATK Rises on FQ3/Guidance – Zacks Tale of the Tape

James Giaquinto — Fri, 05 Sep 2008 16:01:28 +0000

Martek Biosciences (MATK) is up more than 8.5% Friday after the health and nutritional supplements company announced solid fiscal third-quarter results, which included a bump in its 2008 guidance.

Earnings per share reached 28 cents in the quarter, which topped the consensus by more than 16%. Last year, the company earned 19 cents in the same quarter. Revenues advanced 14% to $88.4 million from $77.8 million. MATK was bolstered by its core infant formula business.

MATK now expects earnings per share between $1.06 and $1.09 for the full fiscal year, which is up from its previous guidance and would mark a significant advance of year-ago levels.

MATK is a Zacks #3 Rank company with earnings estimates that have been steady over the past 2 months. However, that could change in the near future as analysts pour over its quarterly report and guidance.

"MATK" Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research

Stock Market News & Stocks to Watch from StraightStocks » Martek Biosciences

Cereplast, Inc. (CERP.OB) to Transform Algae into Bioplastics with Breakthrough Technology

MATK Rises on FQ3/Guidance – Zacks Tale of the Tape